KalVista Pharmaceuticals (KALV) Reports Q1 Loss of $0.47/Share

KalVista Pharmaceuticals (NASDAQ: KALV) reported Q1 EPS of ($0.47), versus ($0.51) reported last year. Revenue for the quarter came in at $3.7 million, versus $10 thousand reported last year.

For earnings history and earnings-related data on KalVista Pharmaceuticals (KALV) click here.

You May Also Be Interested In

• AI and memory not a classic bubble, but future returns uncertain - strategist
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Arthur J. Gallagher (AJG) PT Lowered to $250 at Keefe, Bruyette & Woods